# Alex Colville

> Alex Colville is a Series A investor at age1 backing Biotechnology and Pet. See 2 investments, round sizes, portfolio and contact details. Updated Oct 2026.

- Type: Angel Investor
- Fund: [age1](https://shizune.co/investors/profile/age-1)
- Location: San Francisco, United States
- Total investments: 2
- Last investment: Feb 2026
- Lead investor: 100%
- Last updated: Oct 2026
- LinkedIn: https://www.linkedin.com/in/alexcolville

Alex Colville is a General Partner at age1.

## Contacts

5 contacts available for Alex Colville: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/alex-colville-cfcf?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Pet | 1 | 50% |
| Veterinary | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Series C | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Ireland | 1 | 50% |
| United States | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Loyal | Loyal is a veterinary biotechnology company that develops pharmaceutical therapies for dogs aimed at extending their healthy lifespan and delaying age-associated diseases. It researches and formulates drug candidates designed to address the biological mechanisms of aging in different dog populations, including senior and large-breed dogs, withproducts progressing through clinical and regulatory pathways. Loyal engages in clinical studies and collaborates with veterinary professionals to advance its therapeutic programs and share scientific insights with the broader field. The company publishes research summaries to support transparency and enable other practitioners to build on its findings. | $100M | Series C | Feb 11, 2026 | https://loyalfordogs.com |
| Aerska | Aerska is a biotechnology company that is creating RNA medications to treat, postpone, and prevent brain disorders. | $39M | Series A | Feb 09, 2026 | https://www.aerska.com |

2 of 2 investments shown.

## Co-investors
- [LSP Dementia Fund](https://shizune.co/investors/profile/lsp-dementia-fund) — VC Fund, 2 deals together
- [Baillie Gifford](https://shizune.co/investors/profile/baillie-gifford) — VC Fund, 1 deal together
- [Iaso Ventures](https://shizune.co/investors/profile/iaso-ventures) — VC Fund, 1 deal together
- [The Longevity Fund](https://shizune.co/investors/profile/the-longevity-fund) — VC Fund, 1 deal together

## About age1

VC Fund · San Francisco, United States

Longevity is at an inflection point. Due to scientific advances over the last 30 years, we are beginning to change how we interact with chronological age, living a longer number of healthy years than ever before. Here and now, we embark on this journey. Longevity Fund is launching Age 1, a 4-month program based in SF which offers both capital andhelp to launch founder-driven biotechnology companies. We are selecting a small group of innovative scientists and technologists who are working to extend human healthspan to bring to San Francisco.

3 contacts available at age1.

| Name | Title | Profile |
| --- | --- | --- |
| Alex Colville | General Partner | https://shizune.co/investors/profile/alex-colville-cfcf |
| Laura Deming | Partner | https://shizune.co/investors/profile/laura-deming-2 |
| Omri Amirav-Drory | Mentor | https://shizune.co/investors/profile/omri-amirav-drory |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Alex Colville invest in?

Alex Colville invests primarily in Biotechnology, Pet and Veterinary startups, most often at Series A and Series C stage. Most of the 2 investments tracked by Shizune back companies in Ireland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Alex Colville?

Public channels for Alex Colville include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Alex Colville last invest?

The most recent investment recorded for Alex Colville closed in Feb 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co